gastroesophageal-reflux-disease

Documents about gastroesophageal-reflux-disease

• The Role of Gastroesophageal Reflux in Scleroderma Pulmonary Fibrosis#857318ClinicalTrials.gov
• Effect of Nortriptyline in Cortical Representation of Heartburn in Nonerosive Reflux Disease (NERD) Patients#878716ClinicalTrials.gov
• RESULT (REflux Surgery in Lung Transplantation) Preliminary Study Protocol#895190ClinicalTrials.gov
• Epi-GERD Study: Epidemiological Evaluation in Patients With Gastro-Esophageal Reflux Disease (GERD)#882266ClinicalTrials.gov
• Combined Scalp and Ear Acupuncture in Patients With Proton Pump Inhibitor- Dependent Gastroesophageal Reflux Disease#832877ClinicalTrials.gov
• The Proton Pump Inhibitor (PPI) Test for the Extraesophageal Manifestation of GERD#859264ClinicalTrials.gov
• Gastroesophageal reflux disease and the relationship with Helicobacter pylori#954943Koc University Digital Collections
• A Pre-market, Two-stages Interventional Clinical Investigation to Evaluate the Safety and the Performance of Fibroin Syrup in Reducing the Gastroesophageal Reflux Disease (GERD) Symptomatology in Nonerosive Reflux Disease (NERD) Patients#892863ClinicalTrials.gov
• The Difference of Reflux Pattern Between the Patients Who Have Postprandial Reflux Symptoms#840989ClinicalTrials.gov
• Esophageal Cancer Risk Registry#867537ClinicalTrials.gov
• Biomarkers of Airway Disease, Barrett's and Underdiagnosed Reflux Noninvasively (BADBURN)#871928ClinicalTrials.gov
• The Effect of Dexrabeprazole on Intragastric and Intraesophageal Acidity#842269ClinicalTrials.gov
• Randomized, Double Blind, Placebo Control Trial to Evaluate the Efficacy of Wu-Chu-Yu Tang on Gastroesophageal Reflux Disease (GERD)#862621ClinicalTrials.gov
• PPI Test in GP Patients#849538ClinicalTrials.gov
• Important Correlation Between Anxiety and Reflux Symptoms in Patients With Gastroesophageal Reflux Disease#1010922ClinicalTrials.gov
• Thresholds of Straight Leg Raise Maneuver During High-Resolution-Manometry#861833ClinicalTrials.gov
• The Primary Symptoms of GERD(Gastroesophageal Reflux Disease) in Chinese Outpatients in Gastroenterology Department#885088ClinicalTrials.gov
• Development of Machine Learning Models to Predict Postoperative GERD Symptom Resolution After Laparoscopic Nissen Fundoplication#871028ClinicalTrials.gov
• Efficacy of Dexlansoprazole MR on Heartburn Control in Participants Previously Receiving Twice Daily Proton Pump Inhibitor Therapy#838189ClinicalTrials.gov
• Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 2, Therapeutic Exploratory Study)#838568ClinicalTrials.gov
• The CALIBER Study Randomized Controlled Trial of LINX Versus Double-Dose Proton Pump Inhibitor Therapy for Reflux Disease#828102ClinicalTrials.gov
• A Post-Approval Study of the LINX® Reflux Management System#829175ClinicalTrials.gov
• The Johns Hopkins Heartburn Center Registry#832678ClinicalTrials.gov
• Nasopharyngeal 24 Hour pH Monitoring in Health Adult Volunteers#806189ClinicalTrials.gov
• Comparison of multichannel intraluminal impedance-pH monitoring and reflux scintigraphy in pediatric patients with suspected gastroesophageal reflux#935014Koc University Digital Collections
• A Retrospective Analysis of Patients With Gastroesophageal Reflux Disease Based on a Prospective Clinical Dataset#897264ClinicalTrials.gov
• Anti-Reflux Mucosectomy in the Treatment of Refractory Gastro-esophageal Reflux#846529ClinicalTrials.gov
• A Multicenter, Randomized, Double-Blind, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg qd and 40 mg qd to Placebo qd in Patients With Heartburn and Sleep Disturbances Associated With Gastroesophageal Reflux Disease (GERD)#843555ClinicalTrials.gov
• On Demand Treatment of Reflux Disease#803519ClinicalTrials.gov
• Endoscopic Injection of Autologous Fat-Derived Cells (SVF) for Adults With Refractory Gastroesophageal Reflux Disease (GERD). (The GERD-REVIVE Pilot Study)#899893ClinicalTrials.gov
• Prevalence and Predictors of Proton Pump Inhibitor Partial Response in Gastroesophageal Reflux Disease in Systemic Sclerosis#826654ClinicalTrials.gov
• Medigus Ultrasonic Surgical Endostapler (MUSE) Registry#827743ClinicalTrials.gov
• Symptom Assessment for Patients With Gastro-esophageal Reflux Disease Receiving Helicobacter Pylori Eradication#967718ClinicalTrials.gov
• Follow-up of Patients Operated Upon for Type II-IV Hiatal Hernia#831291ClinicalTrials.gov
• Relationship of Obesity With GERD Among Nigerians#800218ClinicalTrials.gov
• Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD)#878032ClinicalTrials.gov
• Laparoscopic Nissen Versus Toupet Fundoplication for Hiatal Hernia.#880369ClinicalTrials.gov
• Reflux Disease in Head and Neck Cancer Patients Undergoing Radiation Therapy#906924ClinicalTrials.gov
• GaStroEsophageal effeCt of indobUfen Versus aspiRin in Patients Undergoing Dual antiplatElet Therapy#892642ClinicalTrials.gov
• Assessment of the Role of Tegaserod Therapy in the Management of Gastroesophageal Reflux Disease (GERD) Symptoms in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs).#1008679ClinicalTrials.gov
• Assessment of GERD Knowledge Level Among Patients With it in Korea#834206ClinicalTrials.gov
• Study of Dietary Patterns and Food Diversity in Russian GERD Patients#860156ClinicalTrials.gov
• The Use of International GerdQ Questionnaire#826987ClinicalTrials.gov
• Barrett's Esophagus & Gastroesophageal Reflux Disease#1010599ClinicalTrials.gov
• Study Evaluating Pantoprazole in Children With GERD#824847ClinicalTrials.gov
• Study to Evaluate the Performance and Safety of the MARIAL® in Association With PPI Versus PPI Alone#834212ClinicalTrials.gov
• Genotype-supported Versus Conventional Proton Pump Inhibitor Dosing#899890ClinicalTrials.gov
• Evaluation of Upper Esophageal Sphincter Motor Activity in Patients with Extra Esophageal Reflux Symptoms#900483ClinicalTrials.gov
• A prospective single-blind comparative study on the efficacy and safety of ilaprazole 10 mg versus omeprazole 20 mg in patients with gastroesophageal reflux disease and erosive gastritis#453856ARPHA OAI-PMH Endpoint
• Do Laryngeal Tissue Changes in Patients Suspected of Having Laryngopharyngeal Reflux Predict Response to Treatment?#886931ClinicalTrials.gov